Small molecule ERK5 kinase inhibitors paradoxically activate ERK5 signalling: be careful what you wish for. (2020)
Attributed to:
Discovery of ERK5 inhibitors for biomarker-driven clinical evaluation in cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1042/bst20190338
PubMed Identifier: 32915196
Publication URI: http://europepmc.org/abstract/MED/32915196
Type: Journal Article/Review
Volume: 48
Parent Publication: Biochemical Society transactions
Issue: 5
ISSN: 0300-5127